Total Valuation
MacroGenics has a market cap or net worth of CHF241.03M. The enterprise value is $221.70M.
Market CapCHF241.03M
Enterprise Value$221.70M
Share Statistics
MacroGenics has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders2.59%
Owned by Institutions21.53%
Financial Efficiency
MacroGenics’s return on equity (ROE) is -1.34 and return on invested capital (ROIC) is -32.98%.
Return on Equity (ROE)-1.34
Return on Assets (ROA)-0.29
Return on Invested Capital (ROIC)-32.98%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee498.33K
Profits Per Employee-248.73K
Employee Count300
Asset Turnover0.58
Inventory Turnover5.46
Valuation Ratios
The current PE Ratio of MacroGenics is ―. MacroGenics’s PEG ratio is -0.13.
PE Ratio―
PS Ratio0.68
PB Ratio1.83
Price to Fair Value1.83
Price to FCF-1.23
Price to Operating Cash Flow-4.14
PEG Ratio-0.13
Income Statement
In the last 12 months, MacroGenics had revenue of 149.50M and earned -74.62M in profits. Earnings per share was -1.18.
Revenue149.50M
Gross Profit106.32M
Operating Income-72.84M
Pretax Income-75.29M
Net Income-74.62M
EBITDA-59.61M
Earnings Per Share (EPS)-1.18
Cash Flow
In the last 12 months, operating cash flow was -69.96M and capital expenditures -1.73M, giving a free cash flow of -71.69M billion.
Operating Cash Flow-69.96M
Free Cash Flow-71.69M
Free Cash Flow per Share-10.00T>
Dividends & Yields
MacroGenics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta8.31
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
MacroGenics upcoming earnings date is Aug 11, 2026, TBA (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 11, 2026
Ex-Dividend Date―
Financial Position
MacroGenics as a current ratio of 5.10, with Debt / Equity ratio of 172.23%
Current Ratio5.10
Quick Ratio4.92
Debt to Market Cap0.74
Net Debt to EBITDA-0.83
Interest Coverage Ratio-8.56
Taxes
In the past 12 months, MacroGenics has paid -672.00K in taxes.
Income Tax-672.00K
Effective Tax Rate<0.01
Enterprise Valuation
MacroGenics EV to EBITDA ratio is -2.54, with an EV/FCF ratio of -1.82.
EV to Sales1.01
EV to EBITDA-2.54
EV to Free Cash Flow-1.82
EV to Operating Cash Flow-1.87
Balance Sheet
MacroGenics has CHF154.23M in cash and marketable securities with CHF36.51M in debt, giving a net cash position of CHF117.72M billion.
Cash & Marketable SecuritiesCHF154.23M
Total DebtCHF36.51M
Net CashCHF117.72M
Net Cash Per ShareCHF10.00T>
Tangible Book Value Per ShareCHF0.88
Margins
Gross margin is 69.93%, with operating margin of -48.72%, and net profit margin of -49.91%.
Gross Margin69.93%
Operating Margin-48.72%
Pretax Margin-50.36%
Net Profit Margin-49.91%
EBITDA Margin-39.87%
EBIT Margin-44.67%
Analyst Forecast
The average price target for MacroGenics is CHF5.10, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF5.10
Price Target Upside― Downside
Analyst ConsensusModerate Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast―